Tango Therapeutics TNGX CapEx
CapEx at other companies
Other financials
Where this comes from
Reported directly by Tango Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.
The official record: Tango Therapeutics’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Tango Therapeutics's capex.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Tango Therapeutics's capex?
- Tango Therapeutics (TNGX) reported capex of -$2K in Q1 2026.
- How has Tango Therapeutics's capex changed year-over-year?
- Tango Therapeutics's capex decreased by 103.9% year-over-year, from $51K to -$2K.
- What is the long-term trend for Tango Therapeutics's capex?
- Over 4 years (2021 to 2025), Tango Therapeutics's capex has grown at a -13.1% compound annual growth rate (CAGR), from $1.84M to $1.05M.
- What does capex mean?
- Cash spent on property, plant, and equipment — the primary measure of investment in productive capacity and infrastructure.